Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.1B | 972M | 942M |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 291M | 298M | 262M | 293M |
Other operating expenses | 19M | 13M | 15M | 25M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 818M | 728M | 658M | 588M |
Tax provision | 111M | 103M | 90M | 82M |
Net income | 707M | 625M | 568M | 506M |
Basic EPS | 4.5 | 4.0 | 3.6 | 3.2 |
Diluted EPS | 4.5 | 4.0 | 3.6 | 3.2 |
Basic average shares | 157.2M | 157.2M | 157.2M | 157.2M |
Diluted average shares | 157.9M | 157.4M | 157.4M | 157.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 818M | 728M | 658M | 588M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |